Literature DB >> 9324038

Myocardial infarction as a complication of immunoglobulin therapy.

J T Rosenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9324038     DOI： 10.1002/1529-0131(199709)40:9<1732::AID-ART37>3.0.CO;2-2

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  4 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

2.  Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment.

Authors:  N Evangelou; T Littlewood; P Anslow; H Chapel
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 3.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 4.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.